Form 8-K - Current report:
SEC Accession No. 0001558370-21-006821
Filing Date
2021-05-11
Accepted
2021-05-11 16:19:48
Documents
3
Period of Report
2021-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20210511x8k.htm 8-K 31231
2 EX-99.1 tmb-20210511xex99d1.htm EX-99.1 86857
3 GRAPHIC tmb-20210511xex99d1001.jpg GRAPHIC 6192
  Complete submission text file 0001558370-21-006821.txt   127898
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39712 | Film No.: 21911580
SIC: 2834 Pharmaceutical Preparations